Safety of BNT162b2 mRNA COVID-19 vaccine in patients with mast cell disorders

Detalles Bibliográficos
Autores principales: Rosman, Yossi, Lavi, Noa, Meir-Shafrir, Keren, Lachover-Roth, Idit, Cohen-Engler, Anat, Mekori, Yoseph A., Confino-Cohen, Ronit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Clinical Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249677/
https://www.ncbi.nlm.nih.gov/pubmed/34224924
http://dx.doi.org/10.1016/j.jaip.2021.06.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249677/
https://www.ncbi.nlm.nih.gov/pubmed/34224924
http://dx.doi.org/10.1016/j.jaip.2021.06.032

Ejemplares similares